EMERGENT BIOSOLUTIONS INC. Interest Paid, Including Capitalized Interest, Operating and Investing Activities
EMERGENT BIOSOLUTIONS INC. (EBS) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $8.21 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2017-02-28
- EMERGENT BIOSOLUTIONS INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2016 was $8.21M, a 5.92% increase from fiscal 2015.
- EMERGENT BIOSOLUTIONS INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2015 was $7.75M, a 106.09% increase from fiscal 2014.
- EMERGENT BIOSOLUTIONS INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2014 was $3.76M, a 83.02% increase from fiscal 2013.
- EMERGENT BIOSOLUTIONS INC. interest paid, including capitalized interest, operating and investing activities for fiscal 2013 was $2.06M, a 3.84% decline from fiscal 2012.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month |
|---|---|
| 2016-12-31 | $8.21M 10-K · filed 2017-02-28 |
| 2015-12-31 | $7.75M 10-K · filed 2017-02-28 |
| 2014-12-31 | $3.76M 10-K · filed 2017-02-28 |
| 2013-12-31 | $2.06M 10-K · filed 2016-02-29 |
| 2012-12-31 | $2.14M 10-K · filed 2015-03-09 |
| 2011-12-31 | $1.74M 10-K · filed 2014-03-10 |
| 2010-12-31 | $2.18M 10-K · filed 2013-03-08 |
| 2009-12-31 | $1.63M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |